CNM Publications 2009 to Present

Selected Publications

Found 114 results
Author Title Type [ Year(Asc)]
Seo JWoong, Baek H, Mahakian LM, Kusunose J, Hamzah J, Ruoslahti E, Ferrara KW.  2014.  (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque.. Bioconjug Chem. 25(2):231-9.
She Z-G, Liu X, Kotamraju VR, Ruoslahti E.  2014.  Clot-targeted micellar formulation improves anticoagulation efficacy of bivalirudin.. ACS Nano. 8(10):10139-49.
Döring Y, Noels H, Mandl M, Kramp B, Neideck C, Lievens D, Drechsler M, Megens RTA, Tilstam PV, Langer M et al..  2014.  Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication.. Circ Res. 114(6):976-81.
Pang H-B, Braun GB, Friman T, Aza-Blanc P, Ruidiaz ME, Sugahara KN, Teesalu T, Ruoslahti E.  2014.  An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability.. Nat Commun. 5:4904.
Braun GB, Friman T, Pang H-B, Pallaoro A, de Mendoza THurtado, Willmore A-MA, Kotamraju VRamana, Mann AP, She Z-G, Sugahara KN et al..  2014.  Etchable plasmonic nanoparticle probes to image and quantify cellular internalization.. Nat Mater. 13(9):904-11.
Pang H-B, Braun GB, She Z-G, Kotamraju VR, Sugahara KN, Teesalu T, Ruoslahti E.  2014.  A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity.. J Control Release. 175:48-53.
Toba M, Alzoubi A, O'Neill K, Abe K, Urakami T, Komatsu M, Alvarez D, Järvinen TAH, Mann D, Ruoslahti E et al..  2014.  A novel vascular homing peptide strategy to selectively enhance pulmonary drug efficacy in pulmonary arterial hypertension.. Am J Pathol. 184(2):369-75.
Hussain S, Rodriguez-Fernandez M, Braun GB, Doyle FJ, Ruoslahti E.  2014.  Quantity and accessibility for specific targeting of receptors in tumours.. Sci Rep. 4:5232.
Hu Q, Chen R, Teesalu T, Ruoslahti E, Clegg DO.  2014.  Reprogramming human retinal pigmented epithelial cells to neurons using recombinant proteins.. Stem Cells Transl Med. 3(12):1526-34.
Jenning S, Pham T, Ireland SKale, Ruoslahti E, Biliran H.  2013.  Bit1 in anoikis resistance and tumor metastasis.. Cancer Lett. 333(2):147-51.
Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi G-P, Ruoslahti E.  2013.  De novo design of a tumor-penetrating peptide.. Cancer Res. 73(2):804-12.
Zanuy D, Sayago FJ, Revilla-López G, Ballano G, Agemy L, Kotamraju VRamana, Jiménez AI, Cativiela C, Nussinov R, Sawvel AM et al..  2013.  Engineering strategy to improve peptide analogs: from structure-based computational design to tumor homing.. J Comput Aided Mol Des. 27(1):31-43.
Sánchez-Martín D, Sanz L, Ruoslahti E, Álvarez-Vallina L.  2013.  In vivo selection of tumor-specific antibodies.. Oncotarget. 4(10):1547.
Grewal PK, Aziz PV, Uchiyama S, Rubio GR, Lardone RD, Le D, Varki NM, Nizet V, Marth JD.  2013.  Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor.. Proc Natl Acad Sci U S A. 110(50):20218-23.
Lo JH, von Maltzahn G, Douglass J, Park J-H, Sailor MJ, Ruoslahti E, Bhatia SN.  2013.  Nanoparticle amplification via photothermal unveiling of cryptic collagen binding sites.. J Mater Chem B Mater Biol Med. 1(39):5235-5240.
Orr SL, Le D, Long JM, Sobieszczuk P, Ma B, Tian H, Fang X, Paulson JC, Marth JD, Varki N.  2013.  A phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycan-binding proteins.. Glycobiology. 23(3):363-80.